ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET FORECAST 2017-2026

ASIA PACIFIC SURGICAL AND MEDICAL DEVICE MARKET FORECAST 2017-2026

  • November 2017 •
  • 88 pages •
  • Report ID: 5222529
KEY FINDINGS
The Asia-Pacific surgical and medical device market is expected to register a CAGR growth of 6.50% over the forecast period of 2017-2026, raising approximately $ 167205 million by the end of 2026.

MARKET INSIGHTS
Factors like thriving healthcare sector and rise in annual disposable income are highly aiding in the market expansion. The markets of China and India have made considerable progress over the years. The governments of both these countries are relaxing regulations related to the private investments in the surgical and medical device for pharmaceutical and medical industry which has considerably boosted the confidence of the several private players to invest in the Asia-Pacific medical device market. The Australian market is anticipated to evolve with the highest CAGR over the forecast period. The Australian healthcare system is a mixture of public and private sector health service providers with a range of funding and regulatory mechanisms for surgical and medical devices.

COMPETITIVE INSIGHTS
Toshiba Medical Systems Corp (Canon), Johnson & Johnson, Roche Diagnostics, Agilent Technologies, Novartis,Philips Healthcare, 3M Company, Ge Healthcare, Thermo Fisher Scientific, Zimmer Holdings, Abbott Laboratories, Siemens Healthcare, Cryolife Inc, Baxter International,Medtronic, Halyard Health Inc, Smith & Nephew, Danaher, Olympus Corporation, Cardinal Health, Endologix Inc, Stryker Corp and Depuy Synthes are some of the well-known companies in the Asia-Pacific market.
Country=APAC Industry=MedicalDevice ParentIndustry=LifeSciences Date=201711 Topic=MarketSize Publisher=InkwoodResearch Price=2000